GTBP vs REGN: Which Stock is Better?
Side-by-side comparison of Gt Biopharma Inc and Regeneron Pharmaceuticals Inc in 2026
GTBP
Gt Biopharma Inc
$0.73
REGN
Regeneron Pharmaceuticals Inc
$733.78
Key Metrics Comparison
| Metric | GTBP | REGN | Winner |
|---|---|---|---|
| Market Cap | $7.93M | $77.77B | REGN |
| P/E Ratio | N/A | 17.58 | REGN |
| EPS (TTM) | $N/A | $41.75 | REGN |
| Revenue Growth | 0.0% | 0.0% | REGN |
| Gross Margin | 0.0% | 45.8% | REGN |
Analyze GTBP
Full quant analysis
Analyze REGN
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is GTBP or REGN a better investment?
Comparing GTBP and REGN: Gt Biopharma Inc has a market cap of $7.93M while Regeneron Pharmaceuticals Inc has $77.77B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between GTBP and REGN?
GTBP (Gt Biopharma Inc) and REGN (Regeneron Pharmaceuticals Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: GTBP or REGN?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: GTBP or REGN?
REGN has higher revenue growth at 0.0% vs 0.0% for GTBP.
Which company is more profitable: GTBP or REGN?
Regeneron Pharmaceuticals Inc (REGN) has higher gross margins at 45.8% compared to 0.0% for GTBP.
Which is the larger company: GTBP or REGN?
Regeneron Pharmaceuticals Inc (REGN) is larger with a market cap of $77.77B compared to $7.93M for GTBP.
Should I buy GTBP or REGN in 2026?
Both GTBP and REGN have investment merit. GTBP trades at $0.73 while REGN trades at $733.78. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between GTBP and REGN stock?
Key differences: Market Cap ($7.93M vs $77.77B), P/E Ratio (N/A vs 17.6x), Revenue Growth (0.0% vs 0.0%), Gross Margin (0.0% vs 45.8%).